Figure 7From: High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptomsKaplan-Meier survival analyses. The survival analysis was performed with two hundred ninety three (N = 293), because fifteen subjects who had acute malaria at cross sectional survey were excluded. For prospective study of 365-days individuals who responded with total IgG anti ICB2-5 at cross sectional survey had lower malaria attacks (P = 0,019; Log Rank Test).Back to article page